Hiring discrimination laid bare by mountain of data
Analysis of hundreds of thousands of job searches shows that recruiters will discriminate based on ethnicity and gender, and the neural circuitry behind a brief period of forgetting.In this episode:00:47 Hiring discriminationA huge dataset has shown that widespread discrimination occurs in job hiring, based on ethnicity and gender. This backs up decades of research, showing that people from minority backgrounds tend to get contacted far less by employers.Research Article: Hangartner et al.09:31 CoronapodToday Joe Biden becomes the next president of the United States. We find out what this new political chapter could mean f...
Source: Nature Podcast - January 20, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts

Coronapod: The rise of RNA vaccines
Benjamin Thompson, Noah Baker and Elie Dolgin discuss RNA vaccines.In this episode: 01:16 How RNA vaccines came to prominenceIn less than a year, two RNA vaccines against COVID-19 were designed, tested and rolled out across the world. We discuss these vaccines’ pros and cons, how RNA technology lends itself to rapid vaccine development, and what this means for the fight against other diseases.News feature: How COVID unlocked the power of RNA vaccines09:20 The hurdles for trialling new COVID-19 vaccinesMultiple candidates for new COVID-19 vaccines are still being developed, which may offer advantages over the vaccine...
Source: Nature Podcast - January 14, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts

The BMJ Interview - Andrew Pollard on the Oxford/Astra Zeneca vaccine
Andrew Pollard is Director of the Oxford Vaccines Group - who, along with Astra Zeneca, have developed an modified adenovirus vaccine for SARS-CoV-2. In this interview we talk to him about the development of that vaccine - what he thinks about the UK government's plan to increase the interval between doses; if he worries about a mutating virus and vaccine escape; and how the university came to make a deal with a commercial company to provide cost-price vaccinations for the world. www.bmj.com/coronavirus (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 14, 2021 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Coronavirus second wave - The UK ’s fourth lockdown
Recorded Tuesday 5th Jan 2021 As the UK enters lockdown, again, schools are closed, the NHS struggles under the surge of cases, new variants of SARS-COV-2 virus stalk the world, and vaccination programmes make a faltering start. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on critical care, England's vaccination roll out, the closure of schools and why communication is undermining trust in the vaccines. All the BMJ's c...
Source: The BMJ Podcast - January 6, 2021 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Coronapod: The big COVID research papers of 2020
Benjamin Thompson, Noah Baker and Traci Watson discuss some of 2020's most significant coronavirus research papers.In the final Coronapod of 2020, we dive into the scientific literature to reflect on the COVID-19 pandemic. Researchers have discovered so much about SARS-CoV-2 – information that has been vital for public health responses and the rapid development of effective vaccines. But we also look forward to 2021, and the critical questions that remain to be answered about the pandemic.Papers discussedA Novel Coronavirus from Patients with Pneumonia in China, 2019 - New England Journal of Medicine, 24 JanuaryClinical ...
Source: Nature Podcast - December 17, 2020 Category: Science Authors: Springer Nature Limited Source Type: podcasts

Coronavirus second wave - Should we cancel Christmas?
As London and some neighbouring counties move up to tier 3, and Germany, Italy and The Netherlands impose tighter restrictions over over the coming days of Christmas, in this podcast we ask - should Christmas gatherings be cancelled? In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire. They're joined by Mike Tildesley, reader in mathematics at Warwick School of Life Sciences, who models infectious disease spread. They discuss why the key to controlling is pruning network connections - but why that co...
Source: The BMJ Podcast - December 16, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Talk evidence covid-19 update - poor public messaging, and vaccine approval data
The vaccines are being rolled out - but approval is still on an emergency basis, and the evidence underpinning those decisions is only just becoming available for scrutiny. In this podcast we talk to Baruch Fischhoff, professor at Carnegie Mellon University and expert on public health communication about how that messaging should be done. Peter Doshi, associate editor at The BMJ, and vaccine regulation researcher also joins us to talk about the data now released on the vaccine trials - what questions does it raise, and what are the next steps for researching safety. For more on The BMJ's covid-19 coverage www.bmj.com/co...
Source: The BMJ Podcast - December 11, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Don ’t think too deeply about the origin of life – it may have started in puddles
How water chemistry is shifting researchers' thoughts on where life might have arisen, and a new model to tackle climate change equitably and economically.In this episode:00:46 A shallow start to life on Earth?It’s long been thought that life on Earth first appeared in the oceans. However, the chemical complexities involved in creating biopolymers in water has led some scientists to speculate that shallow pools on land were actually the most likely location for early life.News Feature: How the first life on Earth survived its biggest threat — water07:44 CoronapodThe COVID-19 pandemic has massively shifted the scientifi...
Source: Nature Podcast - December 9, 2020 Category: Science Authors: Springer Nature Limited Source Type: podcasts

Coronavirus second wave - the vaccine ’s here, but the pandemic isn’t over
As the first people outside of a trial have started receiving Pfizer's sars-cov-2 vaccine, including Matt, but that's not the end of the story for the pandemic, there are still logistics of rollout, plus treating those who have already contracted the disease. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire. They discuss why it's impossible to get the vaccine into care homes, because of the need for very low temperature storage, why the survival rate in ICU has gone down, and how messaging on the n...
Source: The BMJ Podcast - December 8, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts

How the new COVID-19 vaccines work, and restoring vision with brain implants
Staff Writer Meredith Wadman and host Sarah Crespi discuss what to expect from the two messenger RNA–based vaccines against COVID-19 that have recently released encouraging results from their phase III trials and the short-term side effects some recipients might see on the day of injection. Sarah also talks with researcher Xing Chen, a project co-leader and postdoctoral scientist at the Netherlands Institute for Neuroscience, about using brain stimulation to restore vision. Researchers have known for about 70 years that electrical stimulation at certain points in the brain can lead to the appearance of a phosphene—a s...
Source: Science Magazine Podcast - December 3, 2020 Category: Science Authors: Science Magazine Source Type: podcasts

Cellular ageing: turning back the clock restores vision in mice
A trio of genes may be key to making cells young again, and ultra precise measurement of a fundamental physics constant.In this episode:00:47 Reversing ageingResearchers claim to have identified a method to revert cells in mice eyes back to a younger state.Research article: Lu et al.News and Views: Sight restored by turning back the epigenetic clockNews: Reversal of biological clock restores vision in old mice09:39 CoronapodWe discuss emergency-use approvals for COVID-19 vaccines. Approvals are coming in fast, which presents a dilemma for scientists - they’re critically needed, but what could it mean for research?News: W...
Source: Nature Podcast - December 2, 2020 Category: Science Authors: Springer Nature Limited Source Type: podcasts

Corona virus second wave - Fears for tiers
As the first vaccine for corona virus is approved, and England joins the other nations of the UK outside of full lockdown, we are all entering tiers of restrictions - variable across the country, which will continue until that vaccine coverage is enough to slow transmission in the community. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and are re-joined by Karl Friston, neurologist and member of iSAGE. They discuss what we know about the efficacy of these tiers, and how they interact with thi...
Source: The BMJ Podcast - December 2, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Neutrinos give insights into the workings of the Sun ’s core
Scientists have finally confirmed the existence of a CNO cycle fusion reaction in the Sun, and why women’s contraception research needs a reboot.In this episode:00:47 Detection of CNO neutrinosSince the 1930s it has been theorised that stars have a specific fusion reaction known as the CNO cycle, but proof has been elusive. Now, a collaboration in Italy report detection of neutrinos that show that the CNO cycle exists.Research article: The Borexino CollaborationNews and Views: Neutrino detection gets to the core of the Sun08:48 CoronapodWe discuss the search for the animal origin of SARS-CoV-2, with researchers raiding t...
Source: Nature Podcast - November 25, 2020 Category: Science Authors: Springer Nature Limited Source Type: podcasts

Coronavirus second wave - recentring patients in our covid-19 response
As further promising news emerges of vaccine effectiveness, although still with no data published, and as plans emerge for the return home of university students and limited festive winter celebrations. But as we talked about in the last podcast, there needs to be a concerted effort to re-centre patients and the public within the decisions made about how the NHS will treat covid patients and those with continuing healthcare conditions impacted by the pandemic. National Voices, a coalition of charities that stands for patient centred care, have been talking to patients about what matters to people during COVID-19 and beyo...
Source: The BMJ Podcast - November 24, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Coronapod: What could falling COVID death rates mean for the pandemic?
In this episode:00:44 An increase in survival ratesThe COVID-19 mortality rate is falling around the world. We discuss the reasons behind this – the role of new drugs, the treatment strategies the have been learned, or re-learned, and the ever-present worry that these hard won victories could be undone by rising infection rates.News Feature: Why do COVID death rates seem to be falling?10:53 More vaccine good newsThis week, Moderna released preliminary results for its COVID-19 vaccine candidate, the third positive indication from a string of vaccine announcements. Although the full data are yet to be published, do these r...
Source: Nature Podcast - November 19, 2020 Category: Science Authors: Springer Nature Limited Source Type: podcasts